FDA Application
Federal Register
Monday March 1, 2004
Planning to Submit Comments?
Documents and comments received by the Division of Dockets Management may be posted
on the Internet. Please do not include personal
identifying information, i.e. date of birth, social security number, medical
information, etc., in your correspondence.
Submit Electronic Comments
Documents are on display for public inspection at the Division of Dockets Management, 5630 Fishers Lane (Room 1061), HFA-305, Rockville, MD, 20852; 301-827-6860; TTY/TDD Users 1-800-735-2258.
FDA Federal Register Documents
PROPOSED RULES
Docket No. 2003N-0076, CFSAN 20048. Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer Research to Consider Nutrient Content and Health Claims and Possible Footnote or Disclosure Statements; Reopening of the Comment Period. Pages 9559-9560 [FR Doc. 04-04504] [TXT] [PDF] [PRE-PUB] Comments due April 15, 2004
NOTICES
Docket No. 01P-0333, CDER 2001143. Determination That Cytoxan (Cyclophosphamide for Injection), 2 Gram Vials (NDA 12-142 054), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness. Pages 9630-9631 [FR Doc. 04-04505] [TXT] [PDF] [PRE-PUB]
Table of Contents for Entire Federal Register
Monday, March 1, 2004
(TXT)
(PDF)